VICL (Vical Labs) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Scott H. Davis who wrote (459)	1/6/1998 12:51:00 AM
From: James Yegerlehner	of 1972

All- The news below refers to Genzyme's "proprietary lipid gene delivery systems.." This sure sounds similar to Vical's technology. Does anyone know anything about this technology infringing on Vical's patent, or the other way round? biz.yahoo.com >> ...SGP and the Genzyme Molecular Oncology unit of Genzyme Corp. (Nasdaq:GENZ - news) announced a research and option agreement to combine Genzyme Molecular Oncology's proprietary lipid gene delivery systems with several of SGP's proprietary genes, including the p53 tumor suppressor gene, to develop gene therapy products. <<

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next